DR. GEORGE TOLIS JR., M.D.

Plain English
This study looked at how well patients do in the long term after having a new heart valve inserted using two different methods: getting a new valve again (called repeated TAVR) or removing the old valve and then putting in a new one (called TAVR explantation). Among 1,172 patients needing a second procedure, 70.6% had repeated TAVR, while 29.4% had the valve explantation. While repeated TAVR had lower deaths initially, those who had the valve explantation lived longer overall, with a 5-year survival advantage; their risk of dying after 5 years was 39% lower compared to those who had repeated TAVR. Who this helps: This information helps heart patients who may need another valve procedure and their doctors in deciding the best course of action.

Plain English
This study looked at patients with heart problems caused by previous radiation therapy for cancer, specifically those receiving valve replacement surgery. It found that the type of valve used—mechanical or bioprosthetic—did not significantly affect the patients' short-term complications or long-term survival, with both groups having similar median survival rates around 11 years. However, patients who had surgery for both aortic and mitral valve replacements had worse outcomes, with a median survival of only 6.2 years compared to 13.3 years for those who needed just one valve replaced. Who this helps: This research helps patients with radiation-induced heart disease and their doctors by providing insights into surgery outcomes.

Plain English
This study looked at whether new treatments for heart surgery are better at reducing death rates compared to older methods. Out of 73 analyses involving more than 800 outcomes, they found that most new treatments did not significantly lower mortality compared to older ones; only four randomized trials had strong evidence showing benefits for new treatments. This matters because it suggests that many newer heart surgery interventions may not be more effective than existing ones, raising questions about their use in practice. Who this helps: This helps doctors and patients make informed decisions about treatment options for heart surgery.

Plain English
Researchers studied the effects of a newer blood thinner, rivaroxaban, compared to the traditional medication warfarin in patients who developed atrial fibrillation after heart surgery. They found that both medications resulted in similar hospital stay lengths—7 days for rivaroxaban and 8 days for warfarin—and had similar safety profiles, with no major bleeding or stroke events. However, patients taking rivaroxaban felt it was more convenient and had a better overall experience, while they reported more mobility issues compared to those on warfarin. Who this helps: This information benefits patients recovering from heart surgery and their doctors when choosing anticoagulation treatment.

Plain English
This study looked at the outcomes of a specific heart surgery technique called left internal thoracic artery-left anterior descending artery anastomosis, comparing surgeries performed by medical residents (trainees) versus experienced attending surgeons. They found that among 1,084 heart surgery patients, the rate of serious complications was very similar, with 22.4% of patients treated by residents experiencing major cardiac events compared to 22.8% treated by attending surgeons. This is important because it shows that residents can successfully perform this complex procedure under proper supervision, suggesting that they can gain valuable experience without compromising patient safety. Who this helps: This benefits patients undergoing heart surgery, as it indicates that care can be effectively provided by well-trained residents.

Plain English
This study looked at how the experience level of surgeons affects the success of coronary bypass surgeries. Researchers reviewed 765 cases and found that 10.9% of patients needed a follow-up procedure due to issues with their bypass grafts, but there were no significant differences in complications based on whether a trainee or an experienced surgeon performed the procedures. This is important because it shows that allowing trainees to take a more active role in surgeries doesn’t negatively affect patient outcomes. Who this helps: This benefits patients by ensuring they receive effective care while helping trainees gain essential experience.

Plain English
This study looked at how certain immune cells contribute to atrial fibrillation, a condition that can lead to serious heart issues like strokes. The researchers found that in people with atrial fibrillation, there is a significant increase in inflammatory immune cells, and similar effects were observed in mouse models. They discovered that a specific signaling molecule called SPP1 plays a role in promoting this heart condition, and by blocking it or reducing its effect, they were able to lessen the problem in mice. Who this helps: This research benefits patients with atrial fibrillation and heart disease by pointing to new treatment options.

Plain English
This research focuses on comparing two types of blood thinners, Novel Oral Anticoagulants (NOACs) and Warfarin, for patients who develop a heart rhythm problem called atrial fibrillation after heart surgery. The study aims to determine which treatment is safer, more convenient, and cost-effective. Preliminary findings indicate that NOACs might be better since they reduce the risk of bleeding and require less monitoring compared to Warfarin, but we are waiting for final results to confirm this. Who this helps: This will benefit patients recovering from heart surgery who are at risk for atrial fibrillation.

Plain English
This study looked at whether taking patients off breathing machines (extubation) early after heart surgery affects their chances of needing to be put back on the machine (reintubation). They analyzed data from over 9,500 patients and found that only a small number (1.64% after bypass surgery and 1.5% after valve replacement) needed reintubation. Importantly, they discovered that extubating patients within the first 6 hours after surgery does not increase the risk of needing to be reintubated, but older age does increase that risk. Who this helps: This information benefits patients undergoing heart surgery and their doctors by providing guidance on extubation timing.

Plain English
This study looked at what factors might increase the risk of serious gastrointestinal problems in patients who had open-heart surgery. Out of nearly 7,000 patients, only 52 (0.8%) developed these issues, but certain conditions made them more likely, such as high blood pressure and pre-existing kidney failure, which raised the risk significantly—up to almost six times for those with hypertension. Recognizing these risk factors is important because it can help doctors monitor at-risk patients more closely after surgery, ensuring they get prompt care if complications arise. Who this helps: This helps patients undergoing cardiac surgery and their doctors.

Plain English
This study looked at a rare condition called IgG4-related disease, which can cause inflammation in blood vessels. It focused on a 41-year-old man with severe heart disease who needed surgery. After surgery, doctors found significant thickening around his coronary arteries, and the disease was confirmed by examining his aorta. After starting treatment with prednisone and rituximab, his chest pain improved. Who this helps: This helps patients with IgG4-related disease and their doctors.

Plain English
This study looked at the effect of staff changes during heart surgeries on the accuracy of counting sharp objects like needles and blades. Out of 7,264 surgeries, sharp count errors happened in 723 cases—about 10%. These errors were more common in surgeries that were not the first of the day and on weekends, and they were linked to longer surgery times and a higher chance of in-hospital death. The findings show that reducing staff turnover could help improve patient safety during cardiac surgeries. Who this helps: This helps patients undergoing heart surgery and their healthcare teams.

Plain English
Surgeons performed heart bypass surgery using only artery grafts (instead of veins) by creatively using branches from the patient's internal mammary arteries to bypass three blocked coronary arteries without having to connect them in sequence. This new technique makes it easier for surgeons to give more patients the benefits of all-artery bypass surgery, which lasts longer and produces better long-term survival compared to traditional vein grafts.

Plain English
This study looked at patients who had surgery to replace their aortic valve and examined what factors might predict the development of prolonged atrial fibrillation (AF) afterward. Out of 720 patients, 170 (25%) experienced prolonged AF lasting over 30 days. Researchers found that older patients and those with an enlarged left atrium were more likely to develop this condition, with older age increasing the risk by 5% for each additional year. Who this helps: This research benefits doctors and patients by identifying individuals at higher risk for prolonged AF, guiding potential preventive treatments.

Plain English
This study looked at whether starting elective heart surgeries after 3 pm affects patient safety and hospital costs. Researchers found that out of 2,463 surgeries, 352 (14%) were started late, and these late-start surgeries showed no significant difference in death rates or complications compared to surgeries started earlier. This information is important because it suggests that scheduling surgeries later in the day does not harm patients or increase costs, which could help hospitals optimize their surgical schedules. Who this helps: Patients and hospitals benefit from this finding.

Plain English
This study looked at a specific problem where a type of aortic graft, used in a minimally invasive surgery, moves out of place, a complication known as migration. The researchers presented a case where a migrated graft required a more invasive surgery to fix it, performed while the patient's body was cooled to preserve function. This is important because it highlights the risks associated with these aortic repairs and the need for traditional surgical approaches when complications arise. Who this helps: This helps doctors and surgeons dealing with aortic repair complications.

Plain English
This study looked at whether the number of times an organ donor's lungs were turned down by other patients (called donor sequence number or DSN) affected the health outcomes of those who eventually received a lung transplant. Researchers analyzed data from over 22,000 lung transplant patients and found that a higher DSN did not lead to higher death rates or complications after the transplant. Specifically, even for donors who were rejected more than 50 times, there was no significant difference in survival chances or graft failures compared to those with lower DSNs, making it clear that the number of refusals shouldn’t deter acceptance of these organs. Who this helps: This helps patients needing lung transplants by encouraging the acceptance of organs that may have been previously turned down.

Plain English
This study looked at how a specific brain activity pattern, called burst-suppression, during heart surgery affects the risk of confusion after the operation in older patients. Researchers found that 25% of patients who experienced burst-suppression developed delirium, compared to just 6% in those who did not. The study highlights that brain activity patterns during surgery can influence delirium outcomes, which is crucial for improving recovery strategies for older patients. Who this helps: Older patients undergoing cardiac surgery and their healthcare providers.

Plain English
This study looked at the survival rates of heart transplant patients who were temporarily supported by different devices before their surgery. Researchers found that patients using temporary circulatory support devices (TCS-VAD) had better survival rates after one year (84%) and five years (71%) than those supported by ECMO (79% after one year and 68% after five years). This matters because it highlights that TCS-VADs are a more effective option than ECMO for keeping patients alive until they receive a heart transplant. Who this helps: This benefits heart transplant patients who require temporary support while waiting for a donor organ.

Plain English
This study looked at a rare problem where a heart valve replacement device, called the CoreValve Evolut R, shifted out of place shortly after surgery. In one case, this movement caused a heart attack due to blockage of a coronary artery. The researchers described an effective technique to safely remove the mispositioned valve and replace it with a new one, highlighting that this method simplifies what can be a complicated situation. Who this helps: This helps patients who may experience complications after heart valve replacement surgery.

Plain English
This study looked at how previous heart surgeries affect survival rates after a heart transplant. Researchers analyzed data from nearly 15,000 heart transplant patients and found that those who had previously undergone sternotomy (chest surgery) had a significantly lower chance of survival compared to those receiving their first transplant: the risk of death was 1.13 times higher for those with prior surgeries and 1.68 times higher for those who had a retransplant. These findings are important because they highlight the immediate risks of surgery for patients who have had previous heart procedures, helping to guide better treatment decisions. Who this helps: This helps patients undergoing heart transplants and their doctors in planning safer surgical options.

Plain English
This study looked at the outcomes of heart surgeries performed by trainees under the supervision of experienced surgeons. It found that 3.5% of patients died after surgery, and 21.5% were readmitted, but the results were similar whether the surgery was done by the trainee or the attending surgeon. This matters because it shows that training programs can safely involve residents in significant surgeries without compromising patient outcomes. Who this helps: This benefits patients undergoing cardiac surgeries and the surgical trainees involved in their care.

Plain English
Researchers reviewed how artificial heart valves break down over time and fail, comparing two main types: mechanical valves (which last a long time but require blood thinners) and tissue valves (which don't need blood thinners but deteriorate faster). They found that tissue valve breakdown happens for multiple reasons involving mechanical wear, blood clotting, and immune system reactions, and that newer designs and techniques are helping extend how long these valves last. The choice between valve types should be personalized to each patient's situation, and when valves do fail, surgery to replace them remains the standard treatment, though newer options like inserting new valves without major surgery show promise.

Plain English
This study looked at whether aortic valve replacement (AVR) improves survival for patients with severe aortic regurgitation and a weak heart (low ejection fraction of less than 35%). Out of 40 patients studied, those who had AVR had a much lower death rate of 27.8% compared to 91.2% for those treated with medication alone. The average survival for patients who underwent AVR was about 6.31 years, highlighting that surgery can significantly benefit high-risk patients. Who this helps: This research helps patients with severe aortic regurgitation and low heart function, as well as their doctors making treatment decisions.

Plain English
This study looked at the best options for surgically replacing heart valves in patients with valvular heart disease. It found that mechanical valves last longer and usually don't need to be replaced again, but they require patients to take blood thinners for life, which can lead to bleeding issues. For patients under 60, mechanical valves are recommended unless they can't take blood thinners; patients over 65, or those who are not expected to live long after surgery, should get bioprosthetic valves. Who this helps: This information benefits patients with valvular heart disease and their doctors by guiding their treatment choices.

Plain English
This study looked at whether medical trainees can safely perform heart surgeries on their own while still providing quality care, especially as more patients have multiple health issues. Researchers compared 100 surgeries done entirely by residents (trainees) to surgeries done by experienced surgeons. They found that while the surgeries by trainees took longer—averaging 4.6 hours compared to 2.7 hours for the surgeons—there were no major problems such as deaths or serious complications, demonstrating that trainees can still learn effectively without risking patient safety. Who this helps: This benefits medical trainees and their future patients by allowing more hands-on learning in heart surgery.

Plain English
This study looked at how a medication called dexmedetomidine, which helps induce sleep, could reduce delirium (a form of confusion) in older patients after heart surgery. The researchers are testing this on 370 patients aged 60 and older, with the goal of seeing if those who receive dexmedetomidine experience less delirium on the first day after surgery compared to those given a placebo. The results matter because reducing delirium can improve recovery and hospital experiences for these patients. Who this helps: This helps older patients undergoing heart surgery.

Plain English
This study looked at the outcomes of two types of lung transplants—single-lung transplantation (SLT) and double-lung transplantation (DLT)—for patients with pulmonary fibrosis. It found that DLT has a significantly better 10-year survival rate (55%) compared to SLT (32%). This is especially true for patients younger than 70 years, while those with high lung allocation scores and pulmonary hypertension should be cautious about choosing SLT. Who this helps: This research benefits patients with pulmonary fibrosis who are considering lung transplant options.

Plain English
This study looked at lung transplants from donors whose hearts had stopped beating, known as donation after circulatory death (DCD), and compared their outcomes to those from donors who were declared brain dead (DBD). Out of nearly 21,000 lung transplants in the U.S., only 2% came from DCDs, yet the survival rates for patients receiving DCD lungs were similar to those receiving DBD lungs—about 59% after five years for DCD versus 55% for DBD. The findings show that while initial complications were worse for DCD transplants, patients tended to recover well, indicating that DCD lungs could be a valuable resource. Who this helps: This research benefits lung transplant patients and hospitals looking to expand their donor options.

Plain English
This study looked at a rare type of heart tumor called cardiac papillary fibroelastoma (CPF), which is found in about 0.05% of the population and makes up 10% of all primary heart tumors. Researchers shared a specific case where an atypical CPF was unexpectedly found during an ultrasound of the heart while a patient was having heart surgery. This discovery highlights the need for thorough heart examinations during surgery and shows how important it is to accurately locate these tumors for proper treatment. Who this helps: This helps doctors and cardiac surgeons improve their detection and treatment of heart tumors.

Plain English
This study looked at whether placing a pain relief catheter in the thoracic area before or after lung transplant surgery affects pain management and safety. Researchers found that out of 103 patients, those who had the epidural placed before surgery reported significantly lower pain scores at 48 hours (1.2) and 72 hours (0.8) compared to those who had it placed afterward (2.1 and 1.7, respectively). This is important because it shows that having the epidural before surgery can lead to better pain control without causing more complications. Who this helps: This helps patients undergoing lung transplantation by offering better pain management options.

Plain English
This study looked at a type of heart valve called the Mitroflow aortic bioprosthesis to see how often it deteriorates early and leads to the need for reoperation. Researchers found that 16% of patients with the Mitroflow valve experienced structural valve deterioration within five years, and 5% needed surgery to fix it. In comparison to another commonly used valve, patients with the Mitroflow valve had more deterioration issues and lower survival rates, making it important for doctors to closely monitor patients who receive this valve. Who this helps: This research benefits patients who are considering or have received a Mitroflow aortic valve, as well as doctors involved in their care.

Plain English
This study focused on using echocardiography, a type of heart imaging, to look at a rare heart tumor known as angiosarcoma, which was pressing on the heart's left ventricle. It found that while echocardiograms can’t determine the exact type of tumor, they are effective at spotting where it is and how it affects heart function, such as causing blood flow blockages or valve problems. This is important because it helps doctors assess heart health and make better decisions about treatment. Who this helps: This helps patients with heart tumors and their doctors.

Plain English
This study looked at a specific heart problem called a ventricular septal defect (VSD) that can occur after a heart attack, particularly in patients who have had heart bypass surgery. The researchers reported a unique case where a patient developed this defect six months after the surgery but was successfully treated using a device to support blood flow. This finding is important because it underscores the need for advanced support systems in managing serious heart issues that can arise after heart surgery. Who this helps: This helps patients who experience complications after heart surgery and their doctors in managing those complications effectively.

Plain English
This study looked at how to treat a serious condition called Acute Type A Aortic Dissection, which is a tear in the main artery of the heart. It found that while modern surgical techniques have improved, there is still a high risk of death during surgery, especially with more complex procedures. The researchers hope that using a combination of traditional and newer methods will reduce the chances of complications later on without making surgery riskier. Who this helps: This research benefits patients experiencing Acute Type A Aortic Dissection and their doctors.

Plain English
This study looked at the best ways to treat mitral regurgitation (MR), particularly the kind caused by heart issues (called ischemic mitral regurgitation or IMR). It found that while experts generally agree on aggressive treatment for primary MR, there's much less consensus on how to handle secondary MR, leading to variable outcomes from surgeries. This is important because untreated IMR can lead to serious health problems, and surgeries for it tend to have higher risks compared to other heart surgeries. Who this helps: This helps doctors and patients dealing with heart issues, particularly those with secondary MR.

Plain English
This study focused on a 37-year-old man with multiple tumors called paragangliomas and a growth hormone-producing pituitary tumor, linked to a new mutation in a gene called succinate dehydrogenase subunit D. Researchers found that a type of imaging called F-FDG PET/CT was more effective at finding these tumors than other imaging methods, identifying more lesions in the patient. This matters because better detection of these tumors can lead to more effective treatment options and improved patient outcomes. Who this helps: Patients with paragangliomas and related tumors.

Plain English
This study looked at a specific genetic mutation in a patient with a growth-hormone-producing pituitary tumor and found a connection between this mutation and the development of related tumors called paragangliomas (PGL) and pheochromocytomas (PHEO). The researchers identified a new mutation in the SDHD gene, which was linked to the patient's symptoms and family history of these tumors. They concluded that this genetic mutation might play a significant role in the formation of pituitary tumors in patients with this condition. Who this helps: This benefits patients with genetic predispositions to tumors, particularly those with growth-hormone-producing pituitary tumors.

Plain English
This study looked at whether a specific imaging method called [(18)F]FDG-PET/CT could help find recurring medullary thyroid cancer in patients with high levels of a hormone called calcitonin after their initial treatment. Out of 38 scans done on 32 patients, 18 scans were positive for cancer, with 17 of these being true signs of recurrence. The method was especially effective for patients with very high calcitonin levels, where nearly all (100%) of the scans spotted cancer recurrence, compared to a lower overall detection rate of 60% when excluding a certain patient group. Who this helps: This provides critical information for patients with medullary thyroid cancer and their doctors, particularly those struggling with elevated calcitonin levels and inconclusive standard imaging results.

Plain English
This study looked at how certain genetic conditions, known as multiple neuroendocrine tumor syndromes, can cause problems with reproduction. Researchers found that individuals with these syndromes might experience issues like early puberty or fertility challenges linked to hormone imbalances and tumor development, with specific conditions like McCune-Albright syndrome and Carney complex showing reproductive abnormalities. Recognizing these issues is crucial because they can be early signs of more serious conditions, including various reproductive cancers. Who this helps: Patients with neuroendocrine tumor syndromes and their healthcare providers.

Plain English
This research paper looks at genetic syndromes that cause developmental issues and are linked to obesity in children. It highlights specific conditions like Prader-Willi, Bardet-Biedl, Alstrom, and Carpenter syndromes, revealing that certain genetic changes and problems with cell functioning can lead to obesity. Understanding these genetic mechanisms is crucial because it can help doctors better manage and treat obesity in affected children. Who this helps: This benefits patients with genetic syndromes that cause obesity, their families, and healthcare providers.

Plain English
In this study, researchers looked at the effects of a drug called aprotinin on patients who had coronary artery bypass surgery, comparing them to patients who received a different drug called Amicar. They found that 6.2% of patients treated with aprotinin experienced kidney failure post-surgery, compared to only 2.7% of those treated with Amicar. Additionally, after about 5.4 years, the death rate for aprotinin patients was significantly higher at 43.5% compared to 23.7% for Amicar patients, highlighting a serious risk associated with aprotinin use. Who this helps: This information helps doctors make better decisions about medication choices for patients undergoing heart surgery.